Anti-DHX8/ DDX8/ Dhr2 functional antibody

Anti-DHX8/ DDX8/ Dhr2 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to DHX8/DHX8 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1414-Ab-1/ GM-Tg-hg-SE1414-Ab-2Anti-Human DHX8 monoclonal antibodyHuman
GM-Tg-rg-SE1414-Ab-1/ GM-Tg-rg-SE1414-Ab-2Anti-Rat DHX8 monoclonal antibodyRat
GM-Tg-mg-SE1414-Ab-1/ GM-Tg-mg-SE1414-Ab-2Anti-Mouse DHX8 monoclonal antibodyMouse
GM-Tg-cynog-SE1414-Ab-1/ GM-Tg-cynog-SE1414-Ab-2Anti-Cynomolgus/ Rhesus macaque DHX8 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1414-Ab-1/ GM-Tg-felg-SE1414-Ab-2Anti-Feline DHX8 monoclonal antibodyFeline
GM-Tg-cang-SE1414-Ab-1/ GM-Tg-cang-SE1414-Ab-2Anti-Canine DHX8 monoclonal antibodyCanine
GM-Tg-bovg-SE1414-Ab-1/ GM-Tg-bovg-SE1414-Ab-2Anti-Bovine DHX8 monoclonal antibodyBovine
GM-Tg-equg-SE1414-Ab-1/ GM-Tg-equg-SE1414-Ab-2Anti-Equine DHX8 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1414-Ab-1/ GM-Tg-hg-SE1414-Ab-2; GM-Tg-rg-SE1414-Ab-1/ GM-Tg-rg-SE1414-Ab-2;
GM-Tg-mg-SE1414-Ab-1/ GM-Tg-mg-SE1414-Ab-2; GM-Tg-cynog-SE1414-Ab-1/ GM-Tg-cynog-SE1414-Ab-2;
GM-Tg-felg-SE1414-Ab-1/ GM-Tg-felg-SE1414-Ab-2; GM-Tg-cang-SE1414-Ab-1/ GM-Tg-cang-SE1414-Ab-2;
GM-Tg-bovg-SE1414-Ab-1/ GM-Tg-bovg-SE1414-Ab-2; GM-Tg-equg-SE1414-Ab-1/ GM-Tg-equg-SE1414-Ab-2
Products NameAnti-DHX8 monoclonal antibody
Formatmab
Target NameDHX8
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-DHX8 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1414-Ag-1Recombinant multi-species DHX8/ DDX8/ Dhr2 protein


    Target information

    Target IDGM-SE1414
    Target NameDHX8
    Gene ID1659,217207,287727,713228,480507,101094639,536093,100051804
    Gene Symbol and SynonymsDDX8,Dhr2,DHX8,HRH1,LRRGT00035,mDEAH6,mKIAA4096,PRP22,PRPF22
    Uniprot AccessionQ14562
    Uniprot Entry NameDHX8_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000067596
    Target ClassificationN/A

    The target: DHX8, gene name: DHX8, also named as DDX8, Dhr2, HRH1, PRP22, PRPF22. This gene is a member of the DEAH box polypeptide family. The encoded protein contains the DEAH (Asp-Glu-Ala-His) motif which is characteristic of all DEAH box proteins, and is thought to function as an ATP-dependent RNA helicase that regulates the release of spliced mRNAs from spliceosomes prior to their export from the nucleus. This protein may be required for the replication of human immunodeficiency virus type 1 (HIV-1). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.